8545 Prognostic value of ERCC1 T19007C polymorphism in head and neck squamous cell carcinoma (HNSCC) patients presenting with high- or intermediate-risk features treated with adjuvant chemoradiation (CRT)

Autor:	M. H. H. Federico, F. R. R. Mangone, G. de Castro, Sheila Aparecida Coelho Siqueira, Fatima Solange Pasini, Alberto Rossetti Ferraz, W. Nadalin, I. M. L. Snitcovsky
Rok vydání:	2009
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry medicine.medical_treatment medicine.disease Head and neck squamous-cell carcinoma Internal medicine Medicine ERCC1 business Intermediate risk Adjuvant
Zdroj:	European Journal of Cancer Supplements. 7:483-484
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(09)71636-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::de9fa71053ad2dd6a42b6b10d7896ca1 https://doi.org/10.1016/s1359-6349(09)71636-2 Zobrazit plný text záznamu Full Text from ScienceDirect